Darin Lippoldt

Company: Neurocrine Biosciences

Job title: Chief Legal Officer

Seminars:

Panel Discussion: Addressing Concerns Over Cuts to FDA, NIH, CDC & CMS: What it Means for Innovation, Compliance & Talent Retention 9:30 am

How cuts to agencies like FDA, NIH, CMS, and CDC may delay approvals, complicate drug development, and hinder access to government-supported programs How uncertainty fuels tension between legal teams and commercial functions Navigate a shifting regulatory environment amid “brain drain,” reassignment, and ambiguity around enforcement priorities at agencies including DOJRead more

day: Day 1